Topic: Biotech
Dr. Moira Gunn talks about Australia's unlikely contribution to the science community and it's development of biofuels with Chief Scientist, Dr. Mary O'Kane.
Dr. Moira Gunn talks with Executive Vice President, Thomas Nagy about the positive environmental impacts which occur when manufactures choose to engineer more natural products.
Dr. Moira Gunn speaks with Genencor CEO, Tjerk De Ruiter, to talk about everything sustainable, from tires to toys.
Dr. Moira Gunn learns about adult stem cells from Aldagen CSO,Andrew Balber and talks with QRX Pharma CEO, John Holaday about new uses for existing and proven drugs.
Dr.Moira Gunn and BioTech contributor, David Duncan, sit down with Burrill & Co CEO, Steve Burrill to recap the major events to effect the Bio Technology Industry during 2009.
Dr. Moira Gunn sits down to talk science with writer, James Schwartz about his new book,In Pursuit of the Game:From Darwin to DNA,digging into the world of science and the personalities behind it. From Darwin's belief in pangenesis to explain the inheritance of physical variations to Hermann Muller's Nobel Prize winning work on X-rays and genetic mutation.
Dr. Moira Gunn talks with Jeremy Abbate and his partner, Yali Friedman about a new report published in Scientific American Worldview on the creation of the worlds first environmentally sustainable plastic.
Dr. Moira Gunn speaks with author and columnist,David Ewing Duncan to get the scientific scoop on the latest developments in biotechnology and it's connection to sharkfin soup.
Randy Julian founded Indigo BioSystems in order to bring a modern style of information management -- flexible schemas, linked data -- to the business of drug discovery. In this conversation he explains to host Jon Udell that it's not enough to represent experimental data in standard ways. We also need to describe the experimental design that provides the context for that data.
Dr.Moria Gunn sits down with the president of the Global Vaccines and Infectious Disease, a division of Merck and Company, to talk about the new vaccines on the market.
